545 related articles for article (PubMed ID: 26369416)
21. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Zhao L; Mu B; Zhou R; Cheng Y; Huang C
Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
[TBL] [Abstract][Full Text] [Related]
22. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
23. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
24. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
[TBL] [Abstract][Full Text] [Related]
25. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
26. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
Kseibati MO; Sharawy MH; Salem HA
Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
[TBL] [Abstract][Full Text] [Related]
27. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
[TBL] [Abstract][Full Text] [Related]
28. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
29. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
30. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
31. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.
Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D
PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234
[TBL] [Abstract][Full Text] [Related]
32. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
[TBL] [Abstract][Full Text] [Related]
33. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
[TBL] [Abstract][Full Text] [Related]
34. Protective and anti-inflammatory effect of selenium nano-particles against bleomycin-induced pulmonary injury in male rats.
Shahabi R; Anissian A; Javadmoosavi SA; Nasirinezhad F
Drug Chem Toxicol; 2021 Jan; 44(1):92-100. PubMed ID: 31146593
[TBL] [Abstract][Full Text] [Related]
35. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
[TBL] [Abstract][Full Text] [Related]
36. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
39. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
Pini A; Viappiani S; Bolla M; Masini E; Bani D
J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis.
Luzina IG; Lockatell V; Todd NW; Kopach P; Pentikis HS; Atamas SP
J Pharmacol Exp Ther; 2015 Oct; 355(1):13-22. PubMed ID: 26209236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]